EVOEvotec SE

Nasdaq evotec.com


$ 4.78 $ -0.16 (-3.25 %)    

Friday, 24-May-2024 15:39:04 EDT
QQQ $ 454.82 $ 4.29 (0.95 %)
DIA $ 398.57 $ -0.02 (-0.01 %)
SPY $ 530.36 $ 3.48 (0.66 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ 4.77
$ 4.78
$ 0.00 x 0
$ 0.00 x 0
$ 4.78 - $ 4.82
$ 4.77 - $ 13.49
70,517
na
844.06M
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-evotec-maintains-11-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Evotec (NASDAQ:EVO) with a Buy and maintains $11 price target.

 evotec-q1-eps-007-beats-010-estimate-sales-22669m-beat-22257m-estimate

Evotec (NASDAQ:EVO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 35 p...

Core News & Articles

CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies...

 bayer-and-evotec-collaborate-to-advance-precision-cardiology-financial-terms-undisclosed

Bayer and the German-based life science company, Evotec, announced today that they have updated the focus of their strategic co...

 hc-wainwright--co-maintains-buy-on-evotec-lowers-price-target-to-11

HC Wainwright & Co. analyst Douglas Tsao maintains Evotec (NASDAQ:EVO) with a Buy and lowers the price target from $14 t...

 life-science-focused-evotec-shares-plunge-to-6-year-lows-on-gloomy-annual-forecast

Evotec undergoes a strategic shift for sustainable growth in 2024. Priority reset to optimize operations; expect double-digit r...

 evotec-variant-bio-announce-collaboration-agreement-to-identify-treatment-for-diseases-caused-by-fibrosis

Under the terms of the risk-sharing partnership, Evotec will receive undisclosed research funding and may receive pre-clinical ...

 evotec-and-claris-ventures-streamline-access-to-accelerate-programmes-from-clariss-portfolio-companies-into-the-clinic

Claris's portfolio companies receive easy access to Evotec's full range of pre-clinical and clinical development and ma...

 new-jersey-division-of-gaming-enforcement-has-closed-its-investigation-of-evolution-ab-with-no-further-action

 Evolution AB has been informed by the New Jersey Division of Gaming Enforcement (NJDGE) that it has conducted an investigation...

 evotec-subsidiary-just---evotec-biologics-expands-development-and-manufacturing-agreement-with-abl-for-broadly-neutralising-antibodies-against-hiv-financial-terms-undisclosed

Evotec SE ((Frankfurt Stock Exchange: EVT, MDAX/TecDAX, OTC:EVOTF, NASDAQ:EVO) today announced that its Seattle-based subsidiar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION